Soticlestat

Soticlestat

SCHEMBL20473188

O.O.O.O=C(c1cccnc1-c1ccncc1)N1CCC(O)(Cc2ccccc2)CC1

nearest known ligand 0.98

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CYP46A1

The experimentally established mechanism targets of Soticlestat. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ CYP46A1 known ✓ Q9Y6A2 17/20 0.98
▸ CYP3A4 P08684 1/20 0.98
▸ CYP2C8 P10632 1/20 0.98
▸ CYP2C9 P11712 1/20 0.98
▸ CYP2C19 P33261 1/20 0.98
▸ AVPR1A P37288 1/20 0.56
▸ PKLR P30613 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Soticlestat SCHEMBL31653945 1.00 CYP46A1 (0.98) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
Soticlestat SCHEMBL29469585 0.99 CYP46A1 (1.00) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
Soticlestat SCHEMBL14841089 0.99 CYP46A1 (1.00) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL14840843 0.90 CYP46A1 (0.83) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL14840729 0.89 CYP46A1 (0.78) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL14840913 0.87 CYP46A1 (0.75) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL22728300 0.87 CYP46A1 (0.79) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL14849089 0.87 CYP46A1 (1.00) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL14849079 0.87 CYP46A1 (0.78) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL14849088 0.87 CYP46A1 (0.78) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3363796-B1 METHOD FOR PRODUCING HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICALS CO (JP) 2021-04-07 — — EP disclosed
EP-3363796-A1 METHOD FOR PRODUCING HETEROCYCLIC COMPOUND Takeda Pharmaceutical Company Limited (JP) 2018-08-22 — — EP disclosed
Send feedback